Cargando…

What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients?

Detalles Bibliográficos
Autor principal: Silvestris, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635463/
https://www.ncbi.nlm.nih.gov/pubmed/34864362
http://dx.doi.org/10.1016/j.ebiom.2021.103733
_version_ 1784608306880315392
author Silvestris, Nicola
author_facet Silvestris, Nicola
author_sort Silvestris, Nicola
collection PubMed
description
format Online
Article
Text
id pubmed-8635463
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-86354632021-12-02 What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients? Silvestris, Nicola EBioMedicine Commentary Elsevier 2021-12-01 /pmc/articles/PMC8635463/ /pubmed/34864362 http://dx.doi.org/10.1016/j.ebiom.2021.103733 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Silvestris, Nicola
What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients?
title What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients?
title_full What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients?
title_fullStr What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients?
title_full_unstemmed What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients?
title_short What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients?
title_sort what is the immunological response to bnt162b2 mrna vaccine in immunocompromised patients?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635463/
https://www.ncbi.nlm.nih.gov/pubmed/34864362
http://dx.doi.org/10.1016/j.ebiom.2021.103733
work_keys_str_mv AT silvestrisnicola whatistheimmunologicalresponsetobnt162b2mrnavaccineinimmunocompromisedpatients